Drug: Vincristine Injury: Disease progression Quarter: 2016Q3
Total Records: 45 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 86137563 | VINCRISTINE | Disease progression | JANSSEN | 0.00 | M | 0 | 20160830 | IT |
| 107918262 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160819 | US | |
| 117764284 | VINCRISTINE | Disease progression | ROCHE | 65.00 YR | F | 0 | 20160825 | CA |
| 117892544 | VINCRISTINE | Disease progression | AMGEN | 65.00 YR | F | 0 | 20160829 | CA |
| 118951622 | VINCRISTINE | Disease progression | PFIZER | 0.00 | 0 | 20160801 | US | |
| 125244781 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160704 | US | |
| 125352661 | Vincristine | Disease progression | CIPLA | 5.00 YR | M | 0 | 20160707 | JP |
| 125387541 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160708 | US | |
| 125387641 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160708 | US | |
| 125425011 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125425021 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125425061 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160709 | GB | |
| 125519601 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160713 | CN | |
| 125524042 | VINCRISTINE | Disease progression | ASTELLAS | 60.19 YR | F | 0 | 20160826 | ES |
| 125550321 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160714 | US | |
| 125550611 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160714 | US | |
| 125553631 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160714 | US | |
| 125554311 | Vincristine | Disease progression | CIPLA | 0.00 | 0 | 20160714 | US | |
| 125569802 | VINCRISTINE | Disease progression | AMGEN | 60.00 YR | F | 0 | 20160825 | ES |
| 125785691 | Vincristine | Disease progression | RANBAXY | 60.00 YR | F | 0 | 20160721 | IN |
Total Records: 45 Number of Pages: 3